choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Gammagard

Gammagard Newsletter
  • 15 most expensive medications for Vizient customers 30 Jul 2024 17:22 GMT

    … Outlook.  Vizient evaluated the medication costs and utilization trends … and ulcerative colitis 3. Gammagard, Privigen, Gamunex-C ( … from solid tumors, and treatment of patients with giant … 20 (pneumococcal 20-valent vaccine) — Prevention of infections and …

  • FDA Filings Roundup 28 Feb 2024 22:09 GMT

    … first and only FDA-approved medicine to reduce allergic … s Humira, for the treatment of adult rheumatoid arthritis … Biotherapeutics, Inc., a biotechnology company developing polyclonal tumor … received approval from the FDA for GAMMAGARD LIQUID [Immune Globulin …

  • FDA starts review of Argenx drug in rare disease CIDP 20 Feb 2024 14:03 GMT

    … disability. At the moment, drug treatment for CIDP relies on corticosteroids … as Takeda’s Hyqvia and Gammagard Liquid, or a procedure … the results of the ADHERE trial, which met its primary … Truyen, Argenx’s chief medical officer. “FDA’s acceptance of the …

  • 20 Fastest Growing Biotech Companies in the US 23 Feb 2024 11:27 GMT

    … possible in biotechnology.  Driving Medical Progress: Biotechnology and Pharmaceutical Industries  The global biotechnology market has … for primary biliary cholangitis treatment. Known for antiviral drugs, it focuses on …

  • FDA changes its mind and approves Takeda’s Eohilia 13 Feb 2024 12:03 GMT

    … of a second trial, the Japanese drugmaker said after the … Medicine. “With Eohilia, it’s gratifying to now have an FDA-approved treatment … approvals for dengue fever vaccine Qdenga and post-transplant … based products Hyqvia and Gammagard Liquid for chronic …

  • Takeda's Gammagard Liquid Wins FDA Approval in CIDP 01 Feb 2024 17:03 GMT

    … from the U.S. FDA for GAMMAGARD LIQUID [Immune Globulin Infusion … This milestone follows the recent FDA approval of HYQVIA [Immune … the efficacy and safety of GAMMAGARD LIQUID in adults with … action of immunoglobulins in the treatment of CIDP in adults …

  • Takeda’s GAMMAGARD LIQUID Approved by FDA for Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) 31 Jan 2024 13:53 GMT

    … U.S. Food and Drug Administration (FDA) has approved GAMMAGARD LIQUID [Immune Globulin … by maintenance doses. For treatment of CIDP, GAMMAGARD LIQUID has not been … Medical Center. “Because CIDP is a progressive and complex disease, multiple treatment …

  • FDA Approves Takeda’s Immune Globulin Infusion, Gammagard Liquid, for Chronic Inflammatory Demyelinating Polyneuropathy 29 Jan 2024 23:26 GMT

    … . “The approval of Gammagard Liquid for treatment of CIDP is an … study participants in the clinical trials of Hyqvia for CIDP … the trial, the majority (88.7%) of patients receiving active drug … of neurology at Cedars-Sinai Medical Center, discussed how the …

  • GAMMAGARD LIQUID 30 Jan 2024 00:03 GMT

    … Infusion (Human) Tradename: GAMMAGARD LIQUID Manufacturer: Takeda Pharmaceuticals U.S.A., Inc …

  • Takeda’s GAMMAGARD LIQUID® Approved by U.S. FDA for Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) 29 Jan 2024 16:22 GMT

    … Food and Drug Administration (FDA) has approved GAMMAGARD LIQUID® [ … Medical Center. “Because CIDP is a progressive and complex disease, multiple treatment … to live attenuated virus vaccines (e.g., … distributed by Takeda Pharmaceutical Company Limited (“Takeda …

Satisfied with the content?

Continue to create your account.